These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 1337110)
1. Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis. Kawaguchi Y; Harigai M; Kitani A; Suzuki K; Kawakami M; Ishizuka T; Hidaka T; Hara M; Kawagoe M; Nakamura H J Rheumatol; 1992 Nov; 19(11):1710-5. PubMed ID: 1337110 [TBL] [Abstract][Full Text] [Related]
2. Cytokine regulation of prolyl 4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis. Kawaguchi Y; Kitani A; Hara M; Harigai M; Hirose T; Suzuki K; Kawakami M; Hidaka T; Ishizuka T; Kawagoe M J Rheumatol; 1992 Aug; 19(8):1195-201. PubMed ID: 1328634 [TBL] [Abstract][Full Text] [Related]
3. Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro. Saika S; Ooshima A; Yamanaka O; Okada Y; Tanaka S; Ohnishi Y Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S214-22. PubMed ID: 8871177 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures by ethyl 3,4-dihydroxybenzoate. Majamaa K; Sasaki T; Uitto J J Invest Dermatol; 1987 Oct; 89(4):405-9. PubMed ID: 2822818 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [TBL] [Abstract][Full Text] [Related]
6. Minocycline does not alter collagen type I metabolism of dermal fibroblasts in culture. Anderegg U; Prieb J; Hildebrandt G; Saalbach A Arch Dermatol Res; 2002 May; 294(3):103-8. PubMed ID: 12029495 [TBL] [Abstract][Full Text] [Related]
7. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. Vuorio T; Kähäri VM; Black C; Vuorio E J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of prolyl hydroxylase activity and collagen biosynthesis by fibrostatin C, a novel inhibitor produced by Streptomyces catenulae subsp. griseospora No. 23924. Ishimaru T; Kanamaru T; Takahashi T; Okazaki H J Antibiot (Tokyo); 1988 Nov; 41(11):1668-74. PubMed ID: 2848793 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I. Rosenbloom J; Saitta B; Gaidarova S; Sandorfi N; Rosenbloom JC; Abrams WR; Hamilton AD; Sebti SM; Kucich U; Jimenez SA Arthritis Rheum; 2000 Jul; 43(7):1624-32. PubMed ID: 10902768 [TBL] [Abstract][Full Text] [Related]
10. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts. Dooley A; Gao B; Shi-Wen X; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR Free Radic Biol Med; 2007 Jul; 43(2):253-64. PubMed ID: 17603934 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060 [TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and antifibrotic effects of mimosine on adult cardiac fibroblasts. Ju H; Hao J; Zhao S; Dixon IM Biochim Biophys Acta; 1998 Nov; 1448(1):51-60. PubMed ID: 9824667 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts. Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662 [TBL] [Abstract][Full Text] [Related]
15. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors. Ihn H; Yamane K; Kubo M; Tamaki K Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480 [TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479 [TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. Ichiki Y; Smith EA; LeRoy EC; Trojanowska M J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017 [TBL] [Abstract][Full Text] [Related]
18. Activation of dermal connective tissue in scleroderma. Kähäri VM Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298 [TBL] [Abstract][Full Text] [Related]
19. Coexpression of alpha and beta subunits of prolyl 4-hydroxylase stabilizes the triple helix of recombinant human type X collagen. Wagner K; Pöschl E; Turnay J; Baik J; Pihlajaniemi T; Frischholz S; von der Mark K Biochem J; 2000 Dec; 352 Pt 3(Pt 3):907-11. PubMed ID: 11104702 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Louneva N; Huaman G; Fertala J; Jiménez SA Arthritis Rheum; 2006 Apr; 54(4):1298-308. PubMed ID: 16575855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]